Research advances in systemic inflammatory response of acute decompensated cirrhosis patients
10.3969/j.issn.1001-5256.2023.01.032
- VernacularTitle:急性失代偿肝硬化患者全身炎症反应的研究进展
- Author:
Hui QUAN
1
,
2
;
Yuyong JIANG
1
;
Yixin HOU
1
;
Tingting JIANG
1
;
Rongbing WANG
1
Author Information
1. Department of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100011, China
2. Graduate School of Beijing University of Chinese Medicine, Beijing 100011, China
- Publication Type:Review
- Keywords:
Liver Cirrhosis;
End Stage Liver Disease;
Bacterial Infections
- From:
Journal of Clinical Hepatology
2023;39(1):205-210
- CountryChina
- Language:Chinese
-
Abstract:
Acute decompensated cirrhosis is a stage of end-stage liver disease during which patients often experience decompensated complications and rapid progression. Systemic inflammatory response is characterized by excessive secretion of inflammatory factors caused by bacterial infection of local tissue and rapid spread to the whole body, thereby affecting the physiological activities of the body and causing organ damage or disorder, and it is a relatively serious inflammatory state. This article elaborates on the occurrence of systemic inflammation, the factors affecting the severity of systemic inflammation, the manifestation of systemic inflammation in different stages of decompensated cirrhosis, and the role of systemic inflammation in complications, in order to gain a deeper understanding of systemic inflammation and apply it in the research and development of new therapies and drugs.
